[Current strategies against multi-drug resistant organisms].

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Context:

• The increasing prevalence of multi-drug resistant organisms (MDRO) poses a significant global health threat.
• Hospital settings require robust infection control and antibiotic stewardship to combat MDRO spread.
• Current therapeutic options for certain MDRO infections remain limited.

Purpose:

• To review the definitions and public health burden of multi-drug resistant organisms (MDRO).
• To summarize current and emerging treatment strategies for MDRO infections.
• To outline general approaches for combating the spread of antibiotic resistance.

Summary:

• Multi-drug resistant organisms (MDRO) present a major public health challenge requiring multifaceted strategies like the German Antibiotic Resistance Strategy (DART).
• While new antibiotics have improved treatment for Methicillin-resistant Staphylococcus aureus (MRSA), effective therapies for carbapenemase-producing Gram-negatives are scarce.
• Colistin-based combination therapies show promise for improving outcomes in patients with carbapenem-resistant Gram-negative infections.

Impact:

• Informing healthcare professionals about the latest treatment options and strategies for managing MDRO infections.
• Highlighting the urgent need for novel antibiotic development against resistant Gram-negative bacteria.
• Providing a comprehensive overview to guide public health policies and clinical practice in combating antibiotic resistance.